Aminoglycoside extended interval dosing in neonates is safe and effective: A meta-analysis

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 90, Issue 4, 2005, Pages

  Nestaas, E ^a,b   Bangstad, H J ^b   Sandvik, L ^b   Wathne, K O ^b  

^a VESTFOLD HOSPITAL TRUST   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; GENTAMICIN;

ANTIBIOTIC THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; HUMAN; META ANALYSIS; NEPHROTOXICITY; NEWBORN; NEWBORN INFECTION; NEWBORN SEPSIS; OTOTOXICITY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BIAS (EPIDEMIOLOGY); DRUG ADMINISTRATION SCHEDULE; HUMANS; INFANT, NEWBORN; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 21644487198     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2004.056317     Document Type: Review

References (37)

1. Moore RD, Smith CR, Lietmon PS. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis 1984;149:443-8.
2. Barza M, Ioonnidis JP, Coppelleri JC, et al. Single or multiple daily doses of aminoglycosides: o meta-analysis. BMJ 1996;312:338-45.
3. 2a Contopoulos-Ioannidis DG, Giotis ND, Boliotso DV, et al. Extended-interval aminoglycoside administration for children: a meta-analysis. Pediatrics 2004;114:e111-18.
4. Bailey TC, Little JR, Littenberg B, et al. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997;24:786-95.
5. Ali MZ, Goetz MB. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997;24:796-809.
6. Ferriols-Lisart R, Alos-Alminana M. Effectiveness and safety of once-daily aminoglycosides: a meta-analysis. Am J Health Syst Pharm 1996;53:1141-50.
7. Munckhof WJ, Grayson ML, Turnidge JD. A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 1996;37:645-63.
8. Galloe AM, Graudal N, Christensen HR, Kampmann JP. Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety. Eur J Clin Pharmacol 1995;48:39-43.
9. Hatala R, Dinh TT, Cook DJ. Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review. Clin Infect Dis 1997;24:810-15.
10. Hatala R, Dinh T, Cook DJ. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med 1996;124:717-25.
11. Juni P, Altman DG, Eager M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:42-6.
12. Campbell D. Factors relevant to the experiments in social settings. Psychoc Bull 1957;54:297-312.
13. Berlin JA, Laird NM, Sacks HS, et al. A comparison of statistical methods for combining event rates from clinical trials. Stat Med 1989;8:141-51.
14. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
15. Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ 1997;315:1533-7.
16. Cucherat M, Boissel JP, Leizorovicz A, et al. A program for the meta-analysis of clinical trials. Comput Methods Programs Biomed 1997;53:187-90.
17. Gooding N, Elias-Jones A, Shenay M. Gentamicin dosing in neonatal patients. Pharm World Sci 2001;23:179-80.
18. Lundergan FS, Glasscock GF, Kim EH, et al. Once-daily gentamicin dosing in newborn infants. Pediatrics 1999;103:1228-34.
19. Langhendries JP, Battisti O, Bertrand JM, et al. Once-a-day administration of amikacin in neonates: assessment of nephrotoxicity and ototoxicity. Dev Pharmacol Ther 1993;20:220-30.
20. Mercado MC, Brodsky NL, McGuire MK, et al. Extended interval dosing of gentamicin in preterm infants. Am J Perinatol 2004;21:73-7.
21. Kosalaraksa P, Janthep P, Jirapradittha J, et al. Once versus twice daily dase of gentamicin therapy in Thai neonates. J Med Assoc Thai 2004;87:372-6.
22. Alsaedi SA. Once daily gentamicin dosing in full term neonates. Saudi Med J 2003;24:978-81.
23. Hayani KC, Hatzopaulos FK, Frank AL, et al. Pharmacokinetics of once-daily dosing of gentamicin in neonates. J Pediatr 1997;131:76-80.
24. Skopnik H, Wallraf R, Nies B, et al. Pharmacokinetics and antibacterial activity of daily gentamicin. Arch Dis Child 1992;67:57-61.
25. Chotigeat U, Narongsanti A, Ayudhya DP. Gentamicin in neonatal infection: once versus twice daily dosage. J Med Assoc Thai 2001;84:1109-15.
26. Solomon R, Kuruvilla KA, Job V, et al. Randomized controlled trial of once vs. twice daily gentamicin therapy in newborn. Indian Pediatr 1999;36:133-7.
27. Thureen PJ, Reiter PD, Gresores A, et al. Once- versus twice-daily gentamicin dosing in neonates >/ = 34 weeks' gestation: cost-effectiveness analyses. Pediatrics 1999;103:594-8.
28. Agarwal G, Rastogi A, Pyati S, et al. Comparison of once-daily versus twice-daily gentamicin dosing regimens in infants > or = 2500 g. J Perinatol 2002;22:268-74.
29. de Alba RC, Gomez CE, Manzanares SC, et al. Once daily gentamicin dosing in neonates. Pediatr Infect Dis J 1998;17:1169-71.
30. Krishnan L. George SA. Gentamicin therapy in preterms: a comparison of two dosage regimens, Indian Pediatr 1997;34:1075-80.
31. Kotze A, Bartel PR, Sommers DK. Once versus twice daily amikacin in neonates: prospective study on toxicity. J Paediatr Child Health 1999;35:283-6.
32. Andrews RE, Day P, Bolsover WJ. Audit of single daily dose gentamicin versus a variable frequency lower dose regimen in term and preterm neonates. Br J Intensive Care 2000;10:42-6.
33. Novelli A, Mazzei T, Fallani S, et al. In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin. J Chemother 1995;7:355-62.
34. Begg EJ, Peddie BA, Chambers ST, et al. Comparison of gentamicin dosing regimens using an in-vitro model. J Antimicrob Chemother 1992;29:427-33.
35. Barclay ML, Begg EJ. Aminoglycoside adaptive resistance: importance for effective dosage regimens. Drugs 2001;61:713-21.
36. Aust G. Vestibulotoxicity and ototoxicity of gentamicin in newborns at risk. Int Tinnitus J 2001;7:27-9.
37. Finitzo-Hieber T, McCracken GH Jr, Roeser RJ, et al. Ototoxicity in neonates treated with gentamicin and kanamycin: results of a four-year controlled follow-up study. Pediatrics 1979;63:443-50.